Costar Group (CSGP) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CSGP Hot Sheet
Price: $30.91 --0%
Revenue Growth %: +13.3%
Financial Fact:
Net income per share - diluted (in dollars per shares): 0.72
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +13.3%
Financial Fact:
Net income per share - diluted (in dollars per shares): 0.72
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Costar Group (NASDAQ: CSGP) reported Q3 EPS of $0.25, $0.02 better than the analyst estimate of $0.23. Revenue for the quarter came in at $499 million versus the consensus estimate of $497.89 million.
GUIDANCE:
Costar Group sees FY2021 EPS of $1.07-$1.08, versus the consensus of $1.05. Costar Group sees FY2021 revenue of $1.935-1.94 billion, versus the consensus of $1.95 billion.
For earnings history and earnings-related data on Costar Group (CSGP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Hyperion DeFi raises FY26 guidance, launches $20M buyback
- BMS myeloma CAR T therapy meets primary endpoint in phase 2 trial
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
